New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B


  • Thomas Berg M.D.

    1. Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité Campus Virchow-Klinikum, Universitätsmedizin Berlin, Berlin, Germany
    Search for more papers by this author

  • Potential conflict of interest: T.B. has received research support from and is a consultant for Hoffmann-La Roche.